Zhifa Wang, PhD

Resident physician
Department II of Hematology Center, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, China
Beijing, Beijing, China (People's Republic)

I am very glad to have the opportunity to report my research on such an occasion. My name is Zhifa Wang, coming from Beijing Key Laboratory of Pediatric Hematology-Oncology, Key Laboratory of Major Diseases in Children, Hemophilia Comprehensive Care Centre, Hematology Centre, National Centre for Children's Health, Ministry of Education, Beijing Children's Hospital, Capital Medical University, Beijing, China. Now, I am learning from Professor Wu Runhui for blood disease Ph.D.

Presentation(s):

• OC 05.1 - Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia

  Saturday, June 22, 2024
  13:00 – 13:15 ICT

• OC 13.4 - Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China

  Sunday, June 23, 2024
  10:15 – 10:30 ICT

• PB0721 - Case Report: Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0604 - Plasma concentration-adjusted dose of eltrombopag for the individualised treatment of immune thrombocytopenia in children：apilot study from Beijing Children’s Hospital

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0702 - Real-World Use of Daratumumab for Children Refractory Chronic Immune Thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• PB0665 - Th1 cells is the predictive factor of early response to rituximab in children with immune thrombocytopenia

  Monday, June 24, 2024
  13:45 – 14:45 ICT